FDA Advisory Panel Recommends Long-Acting Opioid That Could Deter Abuse

    An advisory panel to the Food and Drug Administration (FDA) has recommended approving a long-acting opioid painkiller that the manufacturer says could deter abuse. The company that makes the new drug, Arymo ER, says it comes in a tablet that is extremely hard, making it more difficult to break down and abuse.

    If Arymo comes into contact with liquid, it turns into a sticky gel that is difficult to inject.

    The drug manufacturer, Egalet, acknowledges the drug does not eliminate the risk of abuse if a person tries to snort, chew or inject it, Reuters reports. The FDA is not required to follow its advisory committees’ recommendations, but usually does so.

    By Partnership Staff
    August 2016

    Published

    August 2016

    We use cookies to improve your experience and serve you relevant information. To learn more, read our privacy policy.